1442 completed. 1442 Phase 3, 147 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1442 | Completed 1442 |
| Phase 2 | 147 | Completed 147 |
Follow Hematologic Diseases: new trials by email Literature Review of Hematologic Diseases trials Research Report on Hematologic Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Probiotics Against Erythropoietin Resistance in Chronic Kidney Disease Patients. Erythropoietin + Probiotic, EPO - Anaemia, Chronic Kidney Disease | Phase 3 | Completed | Badr University | 80 | 2026-02-01 | 2026-10-30 |
| Efficacy and Safety of HSK39297 in Anti-C5 Treated PNH Patients With Anemia HSK39297 tablets - Paroxysmal Nocturnal Haemoglobinuria (PNH) | Phase 3 | Completed | Haisco Pharmaceutical Group Co., Ltd. | 36 | 2025-05-12 | 2026-02-11 |
| Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment ICS-LABA, benralizumab, Placebo for Benralizumab - Eosinophilic Asthma | Phase 3 | Completed | AstraZeneca | 130 | 2025-03-28 | 2026-10-16 |
| Zinc for Infection Prevention in Sickle Cell Anemia-2 (ZIPS-2) zinc sulfate, Placebo - Sickle Cell Disease | Phase 2 / Phase 3 | Completed | Indiana University | 100 | 2025-02-10 | 2026-01-30 |
| Recombinant Single-chain Factor VIII (rVIII-SingleChain) in Chinese Participants With Hemophilia A Previously Treated With FVIII Products Recombinant single-chain factor VIII (rVIII-SingleChain) - Congenital Hemophilia A | Phase 3 | Completed | CSL Behring | 62 | 2025-01-09 | 2026-10-23 |
| Efficacy and Safety of HRS-5965 in Patients With PNH Who Are Still Anemia After Anti-C5 Antibody Treatment HRS-5965 capsule - Paroxysmal Nocturnal Hemoglobinuria | Phase 3 | Completed | Chengdu Suncadia Medicine Co., Ltd. | 39 | 2025-01-07 | 2026-01-08 |
| Effectiveness of Oral Iron Therapy in Iron Deficiency Anemia With Daily vs Alternate Day Dosing Ferrous sulphate - Iron Deficiency Anemia, Iron Deficiency Anemia Treatment | Phase 3 | Completed | University of Child Health Sciences and Children's Hospital, Lahore | 60 | 2025-01-07 | 2026-06-16 |
| A Study to Evaluate the Efficacy and Safety of Oral HRS-5965 in Adult Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Who Are Naive to Complement Inhibitor Therapy HRS-5965 capsule, Eculizumab Injection - Paroxysmal Nocturnal Hemoglobinuria | Phase 3 | Completed | Chengdu Suncadia Medicine Co., Ltd. | 76 | 2024-10-25 | 2025-09-11 |
| Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Ravulizumab in Chinese Adults Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Ravulizumab - Paroxysmal Nocturnal Hemoglobinuria, PNH | Phase 3 | Completed | Alexion Pharmaceuticals, Inc. | 18 | 2024-10-10 | 2026-06-05 |
| Recombinant Fusion Protein Linking Coagulation Factor IX With Albumin (rIX-FP) in Chinese Subjects With Hemophilia B Previously Treated With FIX Therapy Recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) - Hemophilia B | Phase 3 | Completed | CSL Behring | 23 | 2024-07-28 | 2026-07-23 |
| Safety and Effectiveness of IHAT in Iron Deficient Pre-menopausal Woman Low dose IHAT, High Dose IHAT, Carob flour - Iron-deficiency | Phase 3 | Completed | RDC Clinical Pty Ltd | 180 | 2024-03-06 | 2025-03-10 |
| Safety and Effectiveness of Iron Hydroxide Adipate Tartrate (IHAT) in Iron Deficient Premenopausal Women Low Dose IHAT, High Dose IHAT, Carob Flour - Iron-deficiency | Phase 3 | Completed | Nemysis Ltd | 180 | 2024-03-05 | 2025-06-04 |
| Comparative Analysis of Oral Iron With Injectable Ferric Carboxymaltose for Post Partum Iron Deficiency Anaemia Ferric Carboxymaltose (FCM) - Anemia, Anemia, Postpartum | Phase 2 / Phase 3 | Completed | ESI-PGIMSR, Basaidarapur | 200 | 2024-03-01 | 2026-06-15 |
| STEP: Phase IIIb Study of Benralizumab to Step-down Maintenance Therapy in Patients With Severe Eosinophilic Asthma Benralizumab - Severe Eosinophilic Asthma | Phase 3 | Completed | AstraZeneca | 504 | 2024-02-28 | 2026-09-03 |
| Phase 3 Clinical Project of Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion Protein FRSW117 - Severe Hemophilia A | Phase 3 | Completed | Hangzhou Gensciences Biopharmaceutical Co., Ltd. | 124 | 2023-12-27 | 2026-09-09 |
| Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia Venofer 200 MG Per 10 ML Injection, Ferrous sulfate - Iron Deficiency Anemia of Pregnancy | Phase 3 | Completed | Arrowhead Regional Medical Center | 518 | 2023-11-21 | 2026-11-09 |
| Comparison of the Efficacy and Safety of Venetoclax in Combination With 3 Days Decitabine (DEC3-VEN) vs. Venetoclax in Combination With Azacitidine (VIALE-A) in the Treatment of Elderly Patients or Unfit, New-diagnosis Acute Myeloid Leukemia Patients Experimental: Venetoclax in combination with Decitabine (+-sorafenib), Active Comparator: Standard dose of Venetoclax + Azacitidine - Elderly AML Patients, Unfit, New-diagnosis AML | Phase 3 | Completed | The Second Affiliated Hospital of Kunming Medical University | 154 | 2023-11-01 | 2026-09-09 |
| A Study to Evaluate P1101 in Japanese PV Patients P1101, Low-dose aspirin, Phlebotomy - Polycythemia Vera (PV) | Phase 3 | Completed | PharmaEssentia Japan K.K. | 21 | 2023-10-17 | 2024-11-08 |
| Study of SAL-0951 Compared to Recombinant Human Erythropoietin in Anemic Patients Receiving Maintenance Hemodialysis SAL-0951 tablets, rHuEPO injection - Anemia | Phase 3 | Completed | Shenzhen Salubris Pharmaceuticals Co., Ltd. | 100 | 2023-09-19 | 2024-12-06 |
| Anemia Studies in CKD: Erythropoiesis Via a Novel PHI Daprodustat - Pediatric (ASCEND-P) Daprodustat - Anaemia | Phase 3 | Completed | GlaxoSmithKline | 4 | 2023-09-06 | 2025-11-10 |
Showing 20 of 1442. Sign in to see all of them.
Anemia (264) · Multiple Myeloma (197) · Leukemia, Myeloid, Acute (153) · Leukemia (131) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (111) · Hemophilia A (99) · Leukemia, Lymphocytic, Chronic, B-Cell (97) · Myelodysplastic Syndromes (82) · Purpura, Thrombocytopenic, Idiopathic (68) · Lymphoma (66) · Renal Insufficiency, Chronic (66) · Anemia, Iron-Deficiency (61) · Neoplasms (54) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (49)
Hemic and Lymphatic Diseases (1442) · Neoplasms (594) · Neoplasms by Histologic Type (566) · Immune System Diseases (518) · Hemorrhagic Disorders (456) · Pathological Conditions, Signs and Symptoms (435) · Pathologic Processes (413) · Immunoproliferative Disorders (383) · Lymphoproliferative Disorders (380) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (293) · Disease Attributes (279) · Cardiovascular Diseases (262) · Leukemia (259) · Vascular Diseases (256)
Dexamethasone (125) · Cyclophosphamide (105) · Cytarabine (103) · Daunorubicin (58) · Methotrexate (58) · Darbepoetin alfa (55) · Vincristine (53) · Epoetin Alfa (49) · Bortezomib (48) · Lenalidomide (48) · Prednisone (48) · Etoposide (44) · Rituximab (43) · Doxorubicin (42) · Mercaptopurine (39)
Hoffmann-La Roche (56) · Amgen (52) · Novartis Pharmaceuticals (38) · Celgene (28) · Children's Oncology Group (28) · Baxalta now part of Shire (27) · GlaxoSmithKline (24) · CSL Behring (22) · American Regent, Inc. (20) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (20) · Pfizer (20) · Novo Nordisk A/S (19) · Janssen Research & Development, LLC (17) · National Cancer Institute (NCI) (17) · M.D. Anderson Cancer Center (16)
United States (682) · Germany (362) · France (351) · Italy (325) · United Kingdom (312) · Canada (307) · Spain (301) · Australia (241) · Poland (230) · Russia (198) · Belgium (194) · Austria (174) · Netherlands (173) · Czechia (167) · Japan (163)
PMID 36005278, PMID 36791280, PMID 26965694, PMID 34932836, PMID 38620092, PMID 39121442, PMID 40750723, PMID 41114449, PMID 19216617, PMID 23343061, PMID 23343062, PMID 26196195, PMID 31221778, PMID 34289038, PMID 35939785, PMID 36749544, PMID 37267439, PMID 37975597, PMID 38363466, PMID 40266025, PMID 40359056, PMID 19671919, PMID 22689675, PMID 23007406, PMID 24970932, PMID 26931631, PMID 28751558, PMID 31196847, PMID 31203241, PMID 31375516, PMID 33131249, PMID 33242441, PMID 33995988, PMID 34362786, PMID 34922648, PMID 35829925, PMID 36184192, PMID 36815378, PMID 36848635, PMID 37042865, PMID 37341189, PMID 37890117, PMID 38023148, PMID 38295280, PMID 38446568, PMID 39091324, PMID 39229471, PMID 39516087, PMID 40386832, PMID 40535755
2016 (34), 2014 (29), 2017 (25), 2009 (24), 2015 (18), 2008 (17), U10CA098543 (15), 2023 (14), 2018 (12), 2005 (11), 2019 (11), U10CA021115 (9), 2004 (7), U01HL069294 (7), U10CA032102 (6)